Denosumab: an Emerging Therapy in Pediatric Bone Disorders
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/article/10.1007/s11914-017-0380-1/fulltext.html
Reference76 articles.
1. Seeman E. Bone modeling and remodeling. Crit Rev Eukaryot Gene Expr. 2009;19(3):219–33.
2. Gosman JH, Stout SD, Larsen CS. Skeletal biology over the life span: a view from the surfaces. Am J Phys Anthropol. 2011;146(Suppl 53):86–98. doi: 10.1002/ajpa.21612 .
3. Hogler W, Ward L. Osteoporosis in children with chronic disease. Endocr Dev. 2015;28:176–95. doi: 10.1159/000381045 .
4. Kovacic N, Croucher PI, McDonald MM. Signaling between tumor cells and the host bone marrow microenvironment. Calcif Tissue Int. 2014;94(1):125–39. doi: 10.1007/s00223-013-9794-7 .
5. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93(2):165–76.
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to Pneumocystis jirovecii pneumonia;Pediatric Nephrology;2024-01-26
2. Using Denosumab as a Nonsurgical Management of Aneurysmal Bone Cysts in the Pelvis;Clinics in Orthopedic Surgery;2024
3. Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document;The Journal of Clinical Endocrinology & Metabolism;2023-12-02
4. RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes;Science Advances;2023-11-03
5. Diagnosis and Management of Osteoporosis in Children and Adolescents;The Ewha Medical Journal;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3